Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
McKinsey
Chinese Patent Office
Deloitte
Cantor Fitzgerald
Farmers Insurance
Moodys
Healthtrust

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208183

« Back to Dashboard

NDA 208183 describes ULTRAVATE, which is a drug marketed by Sun Pharm Inds Inc and Sun Pharm Industries and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ULTRAVATE profile page.

The generic ingredient in ULTRAVATE is halobetasol propionate. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
Summary for 208183
Pharmacology for NDA: 208183
Suppliers and Packaging for NDA: 208183
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183 NDA Sun Pharmaceutical Industries, Inc. 10631-122 N 10631-122-04
ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183 NDA Sun Pharmaceutical Industries, Inc. 10631-122 N 10631-122-51

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.05%
Approval Date:Nov 6, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 6, 2018
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ Try a Free TrialPatent Expiration:Jun 19, 2033Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF A LOTION CONTAINING HALOBETASOL PROPIONATE FOR THE TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES INCLUDING PSORIASIS

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Queensland Health
Medtronic
Cantor Fitzgerald
Harvard Business School
Fish and Richardson
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.